Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
We have cloned a type I serine/threonine kinase receptor, XTrR-I, from Xenopus. XTrR-I (Xenopus transforming growth factor beta-related receptor type I) is expressed in all regions of embryos throughout early development. Overexpression of this receptor does not affect ectoderm or endoderm but dorsalizes the mesoderm such that muscle appears in ventralmesoderm and notochord appears in lateralmesoderm normally fated to become muscle. In addition, overexpression of XTrR-I in UV-treated embryos is able to cause formation of a partial dorsal axis. These results suggest that XTrR-I encodes a receptor which responds in normal development to a transforming growth factor beta-like ligand so as to promote dorsalization. Its function would therefore be to direct mesodermalized tissue into muscle or notochord.
FIG. 1. Nucleotide sequence and the deduced amino acid sequence
of the XTrR-I clone. The N-terminal hydrophobic signal sequence and
transmembrane domain are overlined (thin lines; aa 1-18 and 123-144,
respectively) and the putative N-glycosylation site is underlined (thick
line; aa 39-41). The beginning and end of the kinase domain (aa;
204-495) are indicated by arrows. The cysteine residues in the
extracellular domain are boxed and shaded, and a glycine/serine-rich
sequence (aa 173-199) is boxed by a thick line. The PCR primers that
were used are shown by half arrows (aa 226-231, 328-332, and
375-379), and the end of the open reading frame is marked with an
asterisk (aa 500).
FIG. 2. RNase protection analysis of XTrR-I expression in development. (a) RNase protection analysis of XTrR-I mRNA levels in whole
embryos at early stages of development: stage 1, egg; stage 6, morula; stage 8, midblastula; stage 9½/2, late blastula; stage 11, early gastrula; stage
14, midneurula; and stage 26, tail bud. The stage numbers refer to developmental stages of Xenopus (38). The FGF-receptor (FGF-R) is used as
a loading control. (b) RNase protection analysis of XTrR-I RNA in animal caps (An), marginal zones (MZ), and vegetal poles (Veg) at the early
gastrula stage of development. An X-brachyury (Xbra) analysis of the same material shows that the animal cap and vegetal pole explants are largely
free of contaminating mesodermal tissue. (c) RNase protection analysis of XTrR-I RNA in dorsal mesoderm (D), dorsolateral mesoderm (DL),
and ventral mesoderm (V) at the early gastrula stage of development.
FIG. 3. Injection of XTrR-I mRNA
into the ventral side of 4-cell embryos
causes ectopic muscle expression in the
ventral region. (a) Embryo injected in the
ventral side with 6 ng of ,3-galactosidase
mRNA and stained with the muscle antibody
12/101. (b) Embryo injected in the
ventral side with 6 ng of XTrR-I mRNA
and stained with 12/101. (c) Section of an
.t^ embryo injected with 6 ng of XTrR-I
mRNA and stained with 12/101.
FIG. 4. Injection of XTrR-I mRNA into the lateral region of a
2-cell embryo increases the size of the notochord. (a) Notochord
antibody MZ 15 was used to stain an embryo injected in the lateral
region with 6 ng of 13-galactosidase mRNA (Upper) and an embryo
injected with 6 ng of XTrR-I mRNA (Lower). (b) Section of an embryo
injected laterally with 6 ng of 13-galactosidase mRNA and stained with
MZ 15. (c) Section of an embryo injected laterally with 6 ng of XTrR-I
mRNA and stained with MZ 15.
FIG. 5. Injection of XTrR-I mRNA into UV-treated embryos
creates a partial dorsal axis. Ventralized embryos were produced by
UV irradiation 25 min after fertilization. After irradiation, 6 ng of
XTrR-I mRNAwas injected into one blastomere at the 2-cell stage. (a)
Uninjected, UV-treated embryo. (b) UV-treated embryo injected
with 6 ng of XTrR-I mRNA. (c) Control, uninjected, untreated, sibling
embryo.
Altschul,
Basic local alignment search tool.
1990, Pubmed
Altschul,
Basic local alignment search tool.
1990,
Pubmed
Brummel,
Characterization and relationship of Dpp receptors encoded by the saxophone and thick veins genes in Drosophila.
1994,
Pubmed
Cambridge,
Mechanism of bradykinin-induced plasma extravasation in the rat knee joint.
1995,
Pubmed
Cárcamo,
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
1994,
Pubmed
Dale,
Regional specification within the mesoderm of early embryos of Xenopus laevis.
1987,
Pubmed
,
Xenbase
Dale,
Bone morphogenetic protein 4: a ventralizing factor in early Xenopus development.
1992,
Pubmed
,
Xenbase
Dale,
Secretion and mesoderm-inducing activity of the TGF-beta-related domain of Xenopus Vg1.
1993,
Pubmed
,
Xenbase
Feinberg,
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.
1983,
Pubmed
Franzén,
Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.
1993,
Pubmed
Graff,
Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo.
1994,
Pubmed
,
Xenbase
Gurdon,
A community effect in muscle development.
1993,
Pubmed
,
Xenbase
Hanks,
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.
1988,
Pubmed
Henion,
Retinoic acid selectively promotes the survival and proliferation of neurogenic precursors in cultured neural crest cell populations.
1994,
Pubmed
Jones,
DVR-4 (bone morphogenetic protein-4) as a posterior-ventralizing factor in Xenopus mesoderm induction.
1992,
Pubmed
,
Xenbase
Kato,
Single-cell transplantation determines the time when Xenopus muscle precursor cells acquire a capacity for autonomous differentiation.
1993,
Pubmed
,
Xenbase
Kimelman,
Synergistic induction of mesoderm by FGF and TGF-beta and the identification of an mRNA coding for FGF in the early Xenopus embryo.
1987,
Pubmed
,
Xenbase
Kintner,
Monoclonal antibodies identify blastemal cells derived from dedifferentiating limb regeneration.
,
Pubmed
,
Xenbase
Kondo,
Activin receptor mRNA is expressed early in Xenopus embryogenesis and the level of the expression affects the body axis formation.
1991,
Pubmed
,
Xenbase
Lemaire,
Construction of subtracted cDNA libraries enriched for cDNAs for genes expressed in the mesoderm of early Xenopus gastrulae.
1993,
Pubmed
,
Xenbase
Lemaire,
Expression cloning of Siamois, a Xenopus homeobox gene expressed in dorsal-vegetal cells of blastulae and able to induce a complete secondary axis.
1995,
Pubmed
,
Xenbase
Lemaire,
A role for cytoplasmic determinants in mesoderm patterning: cell-autonomous activation of the goosecoid and Xwnt-8 genes along the dorsoventral axis of early Xenopus embryos.
1994,
Pubmed
,
Xenbase
Lin,
Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.
1992,
Pubmed
Massagué,
The TGF-beta family and its composite receptors.
1994,
Pubmed
Mathews,
Cloning of a second type of activin receptor and functional characterization in Xenopus embryos.
1992,
Pubmed
,
Xenbase
Melton,
Translocation of a localized maternal mRNA to the vegetal pole of Xenopus oocytes.
,
Pubmed
,
Xenbase
Musci,
Regulation of the fibroblast growth factor receptor in early Xenopus embryos.
1990,
Pubmed
,
Xenbase
Nellen,
Receptor serine/threonine kinases implicated in the control of Drosophila body pattern by decapentaplegic.
1994,
Pubmed
Penton,
Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor.
1994,
Pubmed
Sanger,
DNA sequencing with chain-terminating inhibitors.
1977,
Pubmed
Scharf,
Axis determination in eggs of Xenopus laevis: a critical period before first cleavage, identified by the common effects of cold, pressure and ultraviolet irradiation.
1983,
Pubmed
,
Xenbase
Sharpe,
XIF3, a Xenopus peripherin gene, requires an inductive signal for enhanced expression in anterior neural tissue.
1989,
Pubmed
,
Xenbase
Slack,
The role of fibroblast growth factor in early Xenopus development.
1989,
Pubmed
,
Xenbase
Slack,
Inducing factors in Xenopus early embryos.
1994,
Pubmed
,
Xenbase
Smith,
Dorsalization and neural induction: properties of the organizer in Xenopus laevis.
1983,
Pubmed
,
Xenbase
Smith,
Mesoderm-inducing factors in early vertebrate development.
1993,
Pubmed
Smith,
Biochemical specificity of Xenopus notochord.
1985,
Pubmed
,
Xenbase
Smith,
Secreted noggin protein mimics the Spemann organizer in dorsalizing Xenopus mesoderm.
1993,
Pubmed
,
Xenbase
Smith,
Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A.
1990,
Pubmed
,
Xenbase
Suzuki,
A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo.
1994,
Pubmed
,
Xenbase
Thomsen,
Processed Vg1 protein is an axial mesoderm inducer in Xenopus.
1993,
Pubmed
,
Xenbase
Wrana,
TGF beta signals through a heteromeric protein kinase receptor complex.
1992,
Pubmed
Wrana,
Mechanism of activation of the TGF-beta receptor.
1994,
Pubmed
Wrana,
Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex.
1994,
Pubmed